Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

Connecticut InnovationsLatest Sep 23

UltraSight · $24M Series B2 Neurosoft Bioelectronics · $7.5M Seed

4rounds

0led

Healthtech 4

Seed 2, Series B 1, Undisclosed 1

Sep 23, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 2, Series B 1, Undisclosed 1

UltraSight $24M Series B2 Neurosoft Bioelectronics $7.5M Seed Vortex Imaging $12M Undisclosed

Bain Capital VenturesLatest Sep 21

Corridor · $25M Seed Forus · $150M Series C

4rounds

2led

Healthtech 3Biotech 1

Series C+ 2, Seed 1, Series A 1

Sep 21, 2026

Details

New companies 3 · Follow-on 1

Stages: Series C+ 2, Seed 1, Series A 1

Corridor $25M Seed Forus $150M Series C Forus $160M Series A

Calm/Storm VenturesLatest Sep 17

Health Force · €4.2M Seed Aeon · Undisclosed Seed extension

4rounds

0led

Healthtech 4

Seed 3, Undisclosed 1

Sep 17, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 3, Undisclosed 1

Health Force €4.2M Seed Aeon Undisclosed Seed extension SquareMind $18M Pre-Series A

Lumira VenturesLatest Sep 17

Altis Labs · $25M Series A Contraline · $92.5M Series B

4rounds

0led

Healthtech 3Biotech 1

Series B 2, Growth 1, Series A 1

Sep 17, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Growth 1, Series A 1

Altis Labs $25M Series A Contraline $92.5M Series B Nervonik $52.5M Series B

Quiet CapitalLatest Sep 16

Thatch · $108M New funding Assort Health · $120M Series C

4rounds

0led

Healthtech 3Biotech 1

Series C+ 3, Undisclosed 1

Sep 16, 2026

Details

New companies 4 · Follow-on 0

Stages: Series C+ 3, Undisclosed 1

Thatch $108M New funding Assort Health $120M Series C Science Corporation $230M Series C

Tau VenturesLatest Sep 16

Kairon Health · $5M Seed Assort Health · $120M Series C

4rounds

0led

Healthtech 4

Seed 1, Series A 1, Series B 1, Series C+ 1

Sep 16, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 1, Series A 1, Series B 1, Series C+ 1

Kairon Health $5M Seed Assort Health $120M Series C Keebler Health $16M Series A

Upfront VenturesLatest Sep 16

Ayble Health · $16M Series A Kubera Health · $6.5M Seed

4rounds

0led

Healthtech 3Enterprise software 1

Seed 3, Series A 1

Sep 16, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 3, Series A 1

Ayble Health $16M Series A Kubera Health $6.5M Seed CVRD Health $5M Seed

SFC CapitalLatest Sep 9

Anemo Labs · £700K Pre-seed Respiro Diagnostics · £1M Pre-Seed

4rounds

1led

Healthtech 3Biotech 1

Pre-seed 2, Seed 2

Sep 9, 2026

Details

New companies 4 · Follow-on 0

Stages: Pre-seed 2, Seed 2

Anemo Labs £700K Pre-seed Respiro Diagnostics £1M Pre-Seed Healome Therapeutics £2M Seed

Pear VCLatest Sep 8

Forus · $150M Series C Kin Health · $9M Seed

4rounds

0led

Healthtech 4

Series A 2, Seed 1, Series C+ 1

Sep 8, 2026

Details

New companies 3 · Follow-on 1

Stages: Series A 2, Seed 1, Series C+ 1

Forus $150M Series C Kin Health $9M Seed Forus $160M Series A

Peak XV PartnersLatest Sep 7

Nua · Undisclosed Series C Arintra · $25M Series B

4rounds

1led

Healthtech 3Consumer 1

Series B 2, Seed 1, Series C+ 1

Sep 7, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Seed 1, Series C+ 1

Nua Undisclosed Series C Arintra $25M Series B Luminai $38M Series B

Nina CapitalLatest Jul 29

Woodway Assurance · Undisclosed Undisclosed Ladder Health · $7M Seed

4rounds

—led

Healthtech 4

Seed 2, Series A 1, Undisclosed 1

Jul 29, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 2, Series A 1, Undisclosed 1

Woodway Assurance Undisclosed Undisclosed Ladder Health $7M Seed Rivia $15M Series A

Wellington ManagementLatest Jul 22

Crystalys Therapeutics · $130M Series B RQ Bio · $115M Series A

4rounds

—led

Biotech 3Fintech 1

Series A 2, Series B 1, Series C+ 1

Jul 22, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series B 1, Series C+ 1

Crystalys Therapeutics $130M Series B RQ Bio $115M Series A Current $80M Series E

Fidelity Management & Research CompanyLatest Jul 15

AdvanCell · $315M Series D City Therapeutics · $99.5M Series B

4rounds

—led

Biotech 3Climate tech 1

Series C+ 3, Series B 1

Jul 15, 2026

Details

New companies 4 · Follow-on 0

Stages: Series C+ 3, Series B 1

AdvanCell $315M Series D City Therapeutics $99.5M Series B CellCentric $220M Series D

AntlerLatest Jul 2

BRYM · €650K Pre-Seed Alcolase · €1.5M Undisclosed

4rounds

—led

Healthtech 3Biotech 1

Pre-seed 2, Seed 1, Undisclosed 1

Jul 2, 2026

Details

New companies 4 · Follow-on 0

Stages: Pre-seed 2, Seed 1, Undisclosed 1

BRYM €650K Pre-Seed Alcolase €1.5M Undisclosed YOU(th) Health Tech $4.5M Seed

ForbionLatest Jun 24

RQ Bio · $115M Series A CellCentric · $220M Series D

4rounds

—led

Biotech 3Healthtech 1

Series A 3, Series C+ 1

Jun 24, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 3, Series C+ 1

RQ Bio $115M Series A CellCentric $220M Series D Slate Medicines $130M Series A

Mercia VenturesLatest Jun 23

Astral Systems · £23M Series A Semble · £30M Series C

4rounds

—led

Healthtech 3Industrial tech 1

Series A 2, Series C+ 1, Undisclosed 1

Jun 23, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series C+ 1, Undisclosed 1

Astral Systems £23M Series A Semble £30M Series C Flok Health $12.5M Series A

HSGLatest May 18

Full-Life Technologies · $150M Series D+Debt Pulnovo Medical · $100M Strategic

4rounds

—led

Biotech 2Healthtech 2

Series A 2, Undisclosed 2

May 18, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Undisclosed 2

Full-Life Technologies $150M Series D+Debt Pulnovo Medical $100M Strategic Vibrant Therapeutics $61M Series A

McKesson VenturesLatest May 13

BranchLab · $26M Series A Latent · $80M Series A

4rounds

—led

Healthtech 3Biotech 1

Series A 3, Series C+ 1

May 13, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 3, Series C+ 1

BranchLab $26M Series A Latent $80M Series A Midi Health $100M Series D

Apricot CapitalLatest Apr 29

Vivacta Biotechnology · $50M Series A+Vivatides Therapeutics · $54M Series A

4rounds

—led

Biotech 4

Series A 3, Seed 1

Apr 29, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 3, Seed 1

Vivacta Biotechnology $50M Series A+Vivatides Therapeutics $54M Series A Excalipoint Therapeutics $27.7M Seed+

Janus Henderson InvestorsLatest Apr 14

Calyxo · $40M Series F Ambrosia Biosciences · $100M Series B

4rounds

0led

Biotech 3Healthtech 1

Series A 2, Series B 1, Series C+ 1

Apr 14, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series B 1, Series C+ 1

Calyxo $40M Series F Ambrosia Biosciences $100M Series B Poplar Therapeutics $45M Series A+

New Enterprise Associates (NEA)Latest Mar 25

Qualified Health · $125M Series B Translucent · $27M Series A

4rounds

—led

Healthtech 4

Undisclosed 2, Series A 1, Series B 1

Mar 25, 2026

Details

New companies 4 · Follow-on 0

Stages: Undisclosed 2, Series A 1, Series B 1

Qualified Health $125M Series B Translucent $27M Series A Nitra $187M Series A+Series B+Debt

Zeal Capital PartnersLatest Mar 23

Flourish Care · $5.7M Seed Understood Care · $8.4M Pre-Seed+Seed

4rounds

—led

Healthtech 3Biotech 1

Seed 3, Undisclosed 1

Mar 23, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 3, Undisclosed 1

Flourish Care $5.7M Seed Understood Care $8.4M Pre-Seed+Seed SpendRule $2M Seed

LRVHealthLatest Mar 5

Greater Good Health · $20.5M Series B KeyCare · $27.4M Series B

4rounds

—led

Healthtech 4

Series B 2, Series A 1, Series C+ 1

Mar 5, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Series A 1, Series C+ 1

Greater Good Health $20.5M Series B KeyCare $27.4M Series B Daffodil Health $16.3M Series A

Alpha WaveLatest Oct 19

Even Healthcare · $50M Series B Ultrahuman · $70M Funding round

3rounds

0led

Healthtech 2Biotech 1

Series B 1, Series C+ 1, Undisclosed 1

Oct 19, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 1, Series C+ 1, Undisclosed 1

Even Healthcare $50M Series B Ultrahuman $70M Funding round AdvanCell $315M Series D

BDC Capital's Thrive Venture FundLatest Oct 15

Sprout Family · CA$3.6M Seed Bird & Be · $13M Series A

3rounds

3led

Healthtech 3

Pre-seed 1, Seed 1, Series A 1

Oct 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Series A 1

Sprout Family CA$3.6M Seed Bird & Be $13M Series A Blair Health CA$4.2M Pre-seed

EvidencedLatest Oct 15

Otter Health · $8M Seed Ilant Health · $15M Series A

3rounds

1led

Healthtech 3

Series A 2, Seed 1

Oct 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Seed 1

Otter Health $8M Seed Ilant Health $15M Series A Photon $16M Series A

Araya VenturesLatest Oct 14

Stride · £4.6M Seed funding Aeon · Undisclosed Seed extension

3rounds

1led

Healthtech 2Consumer 1

Seed 2, Undisclosed 1

Oct 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 2, Undisclosed 1

Stride £4.6M Seed funding Aeon Undisclosed Seed extension MyARC €2M Undisclosed

Blume VenturesLatest Oct 14

Confido Health · $12.5M Series A extension Ultrahuman · $70M Funding round

3rounds

0led

Healthtech 3

Seed 1, Series A 1, Undisclosed 1

Oct 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Undisclosed 1

Confido Health $12.5M Series A extension Ultrahuman $70M Funding round Mave Health $2.1M Seed

Crosslink CapitalLatest Oct 13

Suki · $90M Series E SOND · $7M Seed

3rounds

0led

Healthtech 3

Seed 1, Series B 1, Series C+ 1

Oct 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series B 1, Series C+ 1

Suki $90M Series E SOND $7M Seed Clasp $20M Series B

NVIDIALatest Oct 13

Doctolib · Undisclosed Planned minority investment Verily Health · Undisclosed March financing extension

3rounds

0led

Healthtech 3

Undisclosed 2, Series C+ 1

Oct 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Undisclosed 2, Series C+ 1

Doctolib Undisclosed Planned minority investment Verily Health Undisclosed March financing extension OpenEvidence $250M Series D

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.